Skip to main content
Gerald Dorn II, MD, Cardiology, Saint Louis, MO

Gerald W Dorn II MD

Adult Congenital Heart Disease


Professor, Internal Medicine, Washington University School of Medicine

Join to View Full Profile
  • 4921 Parkview PlSte 8aSaint Louis, MO 63110

  • Phone+1 314-362-1291

  • Fax+1 314-362-4278

Are you Dr. Dorn?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Gerald Dorn II, MD is a cardiologist in Saint Louis, Missouri. He is currently licensed to practice medicine in Missouri. He is a Professor at Washington University School of Medicine.

Education & Training

  • Medical University of South Carolina
    Medical University of South CarolinaFellowship, Cardiovascular Disease, 1985 - 1987
  • Medical University of South Carolina College of Medicine
    Medical University of South Carolina College of MedicineFellowship, Clinical Pharmacology, 1984 - 1985
  • Medical University of South Carolina
    Medical University of South CarolinaResidency, Internal Medicine, 1981 - 1984
  • Medical University of South Carolina
    Medical University of South CarolinaClass of 1981

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2008 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

Press Mentions

  • Moshi Song
    Moshi SongJuly 6th, 2017

Grant Support

  • Mitofusin 2 as a Nodal Regulator of Mitochondrial Function in CardiomyopathyWASHINGTON UNIVERSITY2024–2030
  • Mitofusin 2 as a Nodal Regulator of Mitochondrial Function in CardiomyopathyWASHINGTON UNIVERSITY2024–2030
  • Mitofusin Agonists to Treat Neurodegenerative DiseaseMITOCHONDRIA IN MOTION, INC.2022–2025